4587

PeptiDream Inc.

ペプチドリーム

Industry
Pharmaceutical
Market
Prime
Accounting standards
IFRS
Consolidation basis
Consolidated

Notes

  • Accounting standards
    IFRS / Since Dec 2022
  • Consolidation basis
    Consolidated / Since Dec 2022

Key metrics

Revenue(thousand JPY)

Dec 2021
9,365,964
Dec 2022
26,852,430
Dec 2023
28,712,194
Dec 2024
46,676,523
Dec 2025
18,521,234

Operating profit(thousand JPY)

Dec 2021
4,418,143
Dec 2022
8,980,196
Dec 2023
6,773,047
Dec 2024
21,113,841
Dec 2025
-5,013,195

Operating profit margin(%)

Dec 2021
47.17
Dec 2022
33.44
Dec 2023
23.59
Dec 2024
45.23
Dec 2025
-27.07

Profit before tax(thousand JPY)

Dec 2021
4,823,652
Dec 2022
6,653,325
Dec 2023
4,353,469
Dec 2024
20,888,805
Dec 2025
-5,312,129

Profit(thousand JPY)

Dec 2021
3,606,407
Dec 2022
7,554,358
Dec 2023
3,035,832
Dec 2024
15,014,922
Dec 2025
-3,749,204

Total assets(thousand JPY)

Dec 2021
26,619,168
Dec 2022
63,865,200
Dec 2023
69,464,013
Dec 2024
92,769,826
Dec 2025
77,033,187

Cash and cash equivalents(thousand JPY)

Dec 2021
11,746,529
Dec 2022
5,247,665
Dec 2023
19,507,861
Dec 2024
48,117,933
Dec 2025
28,682,933

Cash flows from operating activities(thousand JPY)

Dec 2021
6,654,708
Dec 2022
-82,929
Dec 2023
12,420,969
Dec 2024
23,844,988
Dec 2025
-13,276,876

Cash flows from investing activities(thousand JPY)

Dec 2021
-2,283,450
Dec 2022
-27,377,217
Dec 2023
1,302,539
Dec 2024
8,370,789
Dec 2025
-2,053,999

Cash flows from financing activities(thousand JPY)

Dec 2021
66,067
Dec 2022
20,789,451
Dec 2023
264,191
Dec 2024
-2,994,633
Dec 2025
-4,057,705

Return on equity(%)

Dec 2021
15.6
Dec 2022
26.3
Dec 2023
8.4
Dec 2024
30.9
Dec 2025
-6.9

Equity ratio(%)

Dec 2021
93.8
Dec 2022
50.2
Dec 2023
58.1
Dec 2024
61.2
Dec 2025
66.9

Earnings per share(JPY per share)

Dec 2021
27.98
Dec 2022
58.19
Dec 2023
23.41
Dec 2024
115.85
Dec 2025
-28.99

Net assets per share(JPY per share)

Dec 2021
192.39
Dec 2022
246.63
Dec 2023
311.16
Dec 2024
437.63
Dec 2025
398.53

Dividend per share(-)

Dec 2021
-
Dec 2022
-
Dec 2023
-
Dec 2024
-
Dec 2025
-

Payout ratio(-)

Dec 2021
-
Dec 2022
-
Dec 2023
-
Dec 2024
-
Dec 2025
-

Disclaimer

The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.

The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.